Guidance for TransMedics Group (TMDX)
| Period | Range | Estimate | Revenue Range | Revenue Estimate | Target | Details |
|---|---|---|---|---|---|---|
| 2026 | N/A | N/A | $727.00M – 757.00M | $725.00M | = Maintained | Details |
| 2025 | N/A | N/A | $595.00M – 605.00M | $600.40M | = Maintained | Details |
| 2025 | N/A | N/A | $585.00M – 605.00M | $582.10M | = Maintained | Details |
| 2025 | N/A | N/A | $530.00M – 552.00M | $521.60M | = Maintained | Details |
| Q2 2025 | N/A | N/A | $565.00M – 585.00M | $540.50M | = Maintained | Details |
| 2024 | N/A | N/A | $425.00M – 445.00M | $444.40M | = Maintained | Details |
| 2024 | N/A | N/A | $425.00M – 445.00M | $401.50M | = Maintained | Details |
| 2024 | N/A | N/A | $390.00M – 400.00M | $366.90M | = Maintained | Details |
| 2024 | N/A | N/A | $360.00M – 370.00M | $330.20M | = Maintained | Details |
| 2023 | N/A | N/A | $222.00M – 230.00M | $194.18M |  Raised |
Details |
| 2023 | N/A | N/A | $138.00M – 145.00M | $134.71M | Raised |
Details |
| Q3 2023 | N/A | N/A | $180.00M – 190.00M | $174.00M | = Maintained | Details |
| 2022 | N/A | N/A | $67.00M – 75.00M | $66.97M | Raised |
Details |
| 2021 | N/A | N/A | $27.60M – 28.60M | N/A | = Maintained | Details |
